All In MedTech

Device Trial Radar · NCT05903898

Improving Stroke Care in North-Norway Through Artificial Intelligence

Last checked: Nov 20, 2026Latest source record: Jul 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Jun 1, 2023

Primary completion

Oct 31, 2025

Study completion Dec 31, 2030

Sponsor

Lead sponsor
University Hospital of North NorwayAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Nordlandssykehuset HF; Helgeland Hospital Trust; Finnmarkssykehuset HF; Oslo University Hospital
First posted
Jun 15, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion (MeVO) in Northern Norway. Relevant outcomes will be compared between centres with and without available software during the study period.

Conditions

  • Ischemic Stroke

Interventions

  • AI software StrokeSens (Circle NVI)Device

    Computed tomography (CT) and computed tomography angiography (CTA) imaging studies acquired upon admission will be assessed by the AI software StrokeSENS (Circle NVI). StrokeSENS is CE marked and available for clinical diagnostic purposes in the EU and UK.The software will be a decision support tool in addition to standard radiological services available in all primary stroke centers in Northern Norway where image interpretation is done by a radiologist or resident in radiology. The software can automatically evaluate the presence of ischemic changes in the vascular territory of the middle cerebral artery according to the Alberta Stroke Program Early CT Score (ASPECTS) and occlusions in the intracranial segment of the internal carotid artery and the proximal segments of the middle cerebral artery (MCA). Output to radiologists will be automated ASPECT scoring, automated search for LVO or MeVO.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time interval from imaging completion to when a request for patient transfer is recordedTime frame: Within 24 hours of stroke onset

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital of North Norway

    Tromsø, Norway · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.